Welcome to our dedicated page for BRUUSH ORAL CARE WTS news (Ticker: BRSHW), a resource for investors and traders seeking the latest updates and insights on BRUUSH ORAL CARE WTS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect BRUUSH ORAL CARE WTS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of BRUUSH ORAL CARE WTS's position in the market.
Bruush Oral Care Inc. (NASDAQ:BRSH) has priced its initial public offering (IPO) of 3,728,549 units at $4.16 each, aiming to raise approximately $15.5 million before fees. Each unit comprises one share of common stock and one warrant. The IPO is projected to close on August 5, 2022. The company's common stock and warrants have received approval for listing on the Nasdaq Capital Market under the symbols BRSH and BRSHW, respectively. Aegis Capital Corp. is managing the offering, with a 45-day option for additional shares to cover over-allotments.